Copyright
©The Author(s) 2024.
World J Hepatol. Apr 27, 2024; 16(4): 650-660
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.650
Published online Apr 27, 2024. doi: 10.4254/wjh.v16.i4.650
Figure 1 Risk factors for post-transplant malignancy.
Figure 2 Mechanism of action of commonly used immunosuppression drugs following solid organ transplantation.
APC: Antigen presenting cell; IL: Interleukin; MHC: Major histocompatibility complex; mTOR: Mammalian target of rapamycin; NFAT: Nuclear factor of activated T cells.
Figure 3 Search strategy utilised for article selection.
- Citation: Liu D, Youssef MM, Grace JA, Sinclair M. Relative carcinogenicity of tacrolimus vs mycophenolate after solid organ transplantation and its implications for liver transplant care. World J Hepatol 2024; 16(4): 650-660
- URL: https://www.wjgnet.com/1948-5182/full/v16/i4/650.htm
- DOI: https://dx.doi.org/10.4254/wjh.v16.i4.650